Behavioral Health

Emily Largent and Holly Fernandez Lynch of the Perelman School of Medicine are quoted about the clinical uncertainty of new Alzheimer’s drug findings and the FDA’s need to have post-approval trials underway.

Henry Kranzler of the Perelman School of Medicine says that the three current FDA-approved drugs for alcohol use disorder are only modestly better than placebos.

Sandy Capaldi of the Perelman School of Medicine defines agoraphobia and explains what distinguishes it from other anxiety disorders in the context of the pandemic.

An op-ed by Jason Karlawish of the Perelman School of Medicine is quoted encouraging a system of “whealthcare” that integrates monitoring and maintaining mental health and wealth, to foster older adults’ financial well-being.

Russel Ramsay of the Perelman School of Medicine is quoted on the notion of uncertainty as an anxiety generator.

David Oslin of the Perelman School of Medicine discusses the implications of his latest research examining whether genetic testing can be used to help prescribe antidepressants.

Phillip Gehrman of the Perelman School of Medicine says that California’s new school start time laws are a good idea from a circadian-rhythms and mental health perspective, though challenges exist for younger students forced to wait for the bus in the dark.

Dani Bassett of the School of Engineering and Applied Science and Desmond Oathes of the Perelman School of Medicine are quoted on the contrast between brain imaging and the tried-and-true, low-tech clinical interview.

A study by Andy Tan of the Annenberg School for Communication and colleagues finds that vaping habits vary among teens based on race, sexual orientation, and the intersection of those two identities.

David Raizen of the Perelman School of Medicine speaks on the evolutionary importance of sleep, the consequences of sleep deprivation, and the unanswered questions of the sleep process.